Home / News / NIH begins a large Phase 3 clinical trial to test immune modulators for the treatment of COVID-19 / Activ-1
Recent Posts
- Marijuana Component Offers Opioid Alternative by Effectively Treating Dental Pain.
- Join NJ ACTS Special Populations Core Seminar on December 5th at 12pm
- Neighborhood Stress Can Heighten Levels of Maternal Sex Hormones During Pregnancy.
- RBHS 10th Anniversary: A Decade of Commitment to Community Health.
- Exposure to Air Pollution In Utero May Affect Reproductive System Development.
Categories
- News (1,969)
- Publication (1)